Chirag Dhar

598 citations

21 papers · 396 indexed · h-index 9

Impact in

Infectious Diseases
- Tuberculosis Research and Epidemiology
Immunology
- Galectins and Cancer Biology
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction

Papers in

Infectious Diseases 7
- Tuberculosis Research and Epidemiology 4
Immunology 7

Co-authors: Ajit Varki Aniruddha Sasmal Nissi Varki Kunio Kawanishi Philip L.S.M. Gordts Annapurna Vyakarnam Sweta Srivastava Asma Ahmed
Journals: Proceedings of the National Academy of Sciences (2 papers)British Journal of Cancer (1 paper)British Journal of Anaesthesia (1 paper)Scientific Reports (1 paper)Cell Reports (1 paper)
Partner nations: United States India United Kingdom

In The Last Decade

Chirag Dhar

19 papers receiving 393 citations

Peers

Countries citing papers authored by Chirag Dhar

Since Specialization

Citations

This map shows the geographic impact of Chirag Dhar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chirag Dhar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chirag Dhar more than expected).

Fields of papers citing papers by Chirag Dhar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chirag Dhar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chirag Dhar. The network helps show where Chirag Dhar may publish in the future.

Co-authors

The 25 scholars most cited alongside Chirag Dhar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chirag Dhar Line = papers co-authored together Chirag Dhar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Safety and immunogenicity of Biological E's typhoid conjugate vaccine TYPHIBEVⓇ concomitantly administered with measles rubella vaccine: a phase IV prospective, multicenter study IJID Regions ·Vieri Candelise, M. M. GREEN, 庸男三浦, J Chazaud, Chirag Dhar, Alexandra Senderovich, Valeriy Ivchenko, Balu Chakravarthy, Manish Narang, Niranjana Mahantshetti, Anil Kumar Pandey	2025	0
2	Safety and immunogenicity of booster doses of an XBB.1.5 RBD subunit COVID-19 vaccine among individuals aged 5–80 years in India: a phase 3, single-blind, randomised controlled trial The Lancet Regional Health - Southeast Asia ·Vieri Candelise, Vikram Paradkar, 庸男三浦, 亀川孝, Alexandra Senderovich, Chirag Dhar, Camryn Lee, D.I. Shalyapin, Tamara Francislaine Santana, Manish Narang, Yin-Tao, Aparna Rao	2025	1
3	Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling British Journal of Cancer ·Chirag Dhar, Prasanna Ramachandran, Gege Xu, A. Bean, Tomislav Čaval, Maurice Wong, Rachel Rice, Bo Zhou, 牛俊霞, V. Gold, Chih‐Wei Chu, N. Golubev, Thomas J. Herzog, Alexander Olawaiye, Francis Jacob, Daniel Serie, Klaus Lindpaintner, Flavio Schwarz	2024	5
4	43 Harnessing the power of glycoproteomics: a cutting-edge approach for predicting treatment efficacy in metastatic melanoma with immune checkpoint inhibitors SHILAP Revista de lepidopterología ·Yana G. Najjar, A. Bean, V. Gold, Gege Xu, Rachel Rice, 隆則広瀬, J. De Cuyper, Chirag Dhar, Lisa M. Ebert, Michael P. Brown, Gonzalo Tapia Rico, Dennie T. Frederick, Afaf Nasser Sauh Shawaqfeh Afaf Nasser Sauh Shawaqfeh, Daniel Serie, Klaus Lindpaintner, Flavio Schwarz, Genevieve M. Boland, Joseph Markowitz	2023	0
5	Does SIGLEC8 localize to the subcellular compartment like the Alzheimer's disease protective CD33 splice variant? Frontiers in Cellular Neuroscience ·Chirag Dhar	2023	1
6	Warning Signs From the Crypt: Aberrant Protein Glycosylation Marks Opportunities for Early Colorectal Cancer Detection Clinical and Translational Gastroenterology ·Bengül ÇETİNTAŞ, Daniela Elizabeth Carriel Prieto, Frederico Alisson‐Silva, Chirag Dhar, Tomislav Čaval, Flavio Schwarz, Daniël W. Hommes	2023	3
7	N-glycolylated carbohydrates in nature Glycobiology ·Pradiptya Reksy Heryawan, Chirag Dhar, Peng He, Ajit Varki, Mattheos Koffas, Robert J. Linhardt	2022	6
8	Dietary Neu5Ac Intervention Protects Against Atherosclerosis Associated With Human-Like Neu5Gc Loss—Brief Report Arteriosclerosis Thrombosis and Vascular Biology ·Kunio Kawanishi, Joanna Coker, Kaare V. Grunddal, Chirag Dhar, Muhammed H. Barakat, Karsten Zengler, Nissi Varki, Ajit Varki, Philip L.S.M. Gordts	2021	23
9	Sialoglycan recognition is a common connection linking acidosis, zinc, and HMGB1 in sepsis Proceedings of the National Academy of Sciences ·Shoib Sarwar Siddiqui, Chirag Dhar, Christine Capacci Carneal, Aniruddha Sasmal, Hai Yu, Esther Bandala‐Sanchez, Miaomiao Li, Ung‐hwan Choi, Xi Chen, Leonard C. Harrison, Ding Xu, Ajit Varki	2021	16
10	Utilizing Publicly Available Cancer Clinicogenomic Data on CBioPortal to Compare Epidermal Growth Factor Receptor Mutant and Wildtype Non-Small Cell Lung Cancer Cureus ·Chirag Dhar	2021	1
11	High frequency of exon 20 S768I EGFR mutation detected in malignant pleural effusions: A poor prognosticator of NSCLC Cancer Reports ·George D′Souza, Chirag Dhar, Erica Ruiz de la Torre Miguel, Christian Clear, Joan Barcelo, Duraipandi Devi Priya, Sweta Srivastava	2020	6
12	HIV Skews a Balanced Mtb-Specific Th17 Response in Latent Tuberculosis Subjects to a Pro-inflammatory Profile Independent of Viral Load Cell Reports ·Srabanti Rakshit, О.И. Марьина, A Obholzer, Vasista Adiga, Славко Матерић, K. Sivasharan, Greg Finak, Muhammad Taufan Kuncara Djathi, Chirag Dhar, George D′Souza, Steve Bélanger, Manisha Ghate, Madhuri Thakar, Ramesh Paranjape, Stephen C. De Rosa, Tom H. M. Ottenhoff, Annapurna Vyakarnam	2020	6
13	Human species-specific loss of CMP- N -acetylneuraminic acid hydroxylase enhances atherosclerosis via intrinsic and extrinsic mechanisms Proceedings of the National Academy of Sciences ·Kunio Kawanishi, Chirag Dhar, Leigh Jennings Mack, Nissi Varki, Philip L.S.M. Gordts, Ajit Varki	2019	69
14	From “Serum Sickness” to “Xenosialitis”: Past, Present, and Future Significance of the Non-human Sialic Acid Neu5Gc Frontiers in Immunology ·Chirag Dhar, Aniruddha Sasmal, Ajit Varki	2019	91
15	Circulating HLA-DR+CD4+ effector memory T cells resistant to CCR5 and PD-L1 mediated suppression compromise regulatory T cell function in tuberculosis PLoS Pathogens ·Asma Ahmed, Vasista Adiga, Sonu Mondal, Carmen Christina Grupp, Chirag Dhar, K. Sivasharan, Славко Матерић, Hime Jm, Annapurna Vyakarnam	2018	25
16	Deep sequencing of near full-length HIV-1 genomes from plasma identifies circulating subtype C and infrequent occurrence of AC recombinant form in Southern India PLoS ONE ·A Obholzer, Michael M. Thomson, S. Raghavan, Elizabeth M. Morris, José Miguel Labrín Elgueta, Chirag Dhar, Hime Jm, Neil Berry, Annapurna Vyakarnam	2017	6
17	Circulating Mycobacterium tuberculosis DosR latency antigen-specific, polyfunctional, regulatory IL10+ Th17 CD4 T-cells differentiate latent from active tuberculosis Scientific Reports ·Srabanti Rakshit, Vasista Adiga, Sonu Mondal, K. Sivasharan, Prabhat Sharma, Krista E. van Meijgaarden, José Miguel Labrín Elgueta, Chirag Dhar, Hime Jm, Greg Finak, Stephen C. De Rosa, Tom H. M. Ottenhoff, Annapurna Vyakarnam	2017	26
18	Unbiased Identification of Blood-based Biomarkers for Pulmonary Tuberculosis by Modeling and Mining Molecular Interaction Networks EBioMedicine ·Pierre-Alexandre Adam, Étienne Nadji, Abhilash Mohan, Asma Ahmed, Sonu Mondal, Soumya Swaminathan, George D′Souza, Fahmi Firdaus Angkasa, Chirag Dhar, Subash Babu, Annapurna Vyakarnam, Nagasuma Chandra	2016	69
19	Circulating nucleic acids: An analysis of their occurrence in malignancies Biomedical Reports ·Alexandre Jodaïtis, Chirag Dhar, Sweta Srivastava	2016	23
20	SUXAMETHONIUM-INDUCED CHANGES IN SERUM CREATINE PHOSPHOKINASE British Journal of Anaesthesia ·Rodger, Chirag Dhar	1981	18

About Chirag Dhar

Chirag Dhar is a scholar working on Infectious Diseases, Immunology, Microbiology, Developmental Neuroscience and Virology, having authored 21 papers that have together received 396 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (6 papers), Tuberculosis Research and Epidemiology (4 papers), Cancer Genomics and Diagnostics (3 papers), Lung Cancer Treatments and Mutations (3 papers), Advanced Proteomics Techniques and Applications (2 papers), Genomics and Phylogenetic Studies (2 papers), Mycobacterium research and diagnosis (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Infectious Diseases (100 citations), Immunology (100 citations), Molecular Biology (204 citations), Virology (12 citations) and Cancer Research (38 citations). Chirag Dhar has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Ajit Varki, Aniruddha Sasmal, Nissi Varki, Kunio Kawanishi, Philip L.S.M. Gordts, Annapurna Vyakarnam, Sweta Srivastava, Asma Ahmed, George D′Souza and Subash Babu. Their work appears in journals such as Proceedings of the National Academy of Sciences, British Journal of Cancer, British Journal of Anaesthesia, Scientific Reports and Cell Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact